Descriptive epidemiology and attributable morbidity of ventilator-associated events

Infection Control and Hospital Epidemiology

Volumn 35, Issue 5, 2014, Pages 502-510

  Klompas, Michael ^a,b   Kleinman, Ken ^a   Murphy, Michael V ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; CARBAPENEM; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; COLISTIN; COTRIMOXAZOLE; LINEZOLID; MACROLIDE; METRONIDAZOLE; NAFCILLIN; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ARTICLE; ARTIFICIAL VENTILATION; BILIRUBIN BLOOD LEVEL; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COLONY FORMING UNIT; CONTROLLED STUDY; CREATININE BLOOD LEVEL; EXTUBATION; FEMALE; HUMAN; INFECTIOUS COMPLICATION; INTENSIVE CARE UNIT; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; POSITIVE END EXPIRATORY PRESSURE; RETROSPECTIVE STUDY; THROMBOCYTE COUNT; TRACHEAL ASPIRATION PROCEDURE; VENTILATOR ASSOCIATED EVENT; LENGTH OF STAY; MICROBIOLOGY; MORTALITY; PNEUMONIA, VENTILATOR-ASSOCIATED; STATISTICS AND NUMERICAL DATA; TIME; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ANTI-BACTERIAL AGENTS; FEMALE; HOSPITAL MORTALITY; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84898732880     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/675834     Document Type: Article

References (26)

1. Centers for Disease Control and Prevention (CDC). Ventilator-Associated Event Protocol. Atlanta: CDC, 2013. http://www.cdc.gov/nhsn/acute-care-hospital/vae/index.html. Accessed February 25, 2013.
2. Magill SS, Fridkin SK. Improving surveillance definitions for ventilator-associated pneumonia in an era of public reporting and performance measurement. Clin Infect Dis 2012;54(3):378-380.
3. Klompas M. Complications of mechanical ventilation: the CDC's new surveillance paradigm. N Engl J Med 2013;368(16): 1472-1475.
4. Klompas M, Kleinman K, Platt R. Development of an algorithmfor surveillance of ventilator-associated pneumonia with electronic data and comparison of algorithm results with clinician diagnoses. Infect Control Hosp Epidemiol 2008;29(1):31-37.
5. Klompas M, Khan Y, Kleinman K, et al. Multicenter evaluation of a novel surveillance paradigm for complications of mechanical ventilation. PLoS ONE 2011;6(3):e18062.
6. Klompas M, Kleinman K, Khan Y, et al. Rapid and reproducible surveillance for ventilator-associated pneumonia. Clin Infect Dis 2012;54:370-377.
7. Klompas M, Magill S, Robicsek A, et al. Objective surveillance definitions for ventilator-associated pneumonia. Crit Care Med 2012;40(12):3154-3161.
8. Prospero E, Illuminati D, Marigliano A, et al. Learning from Galileo: ventilator-associated pneumonia surveillance. Am J Respir Crit Care Med 2012;186(12):1308-1309.
9. Hayashi Y, Morisawa K, Klompas M, et al. Toward improved surveillance: the impact of ventilator-associated complications on length of stay and antibiotic use in patients in intensive care units. Clin Infect Dis 2013;56(4):471-477.
10. Muscedere J, Sinuff T, Heyland D, et al. The clinical impact and preventability of ventilator-associated conditions in critically ill mechanically ventilated patients. Chest 2013: 144(5) 1453-1460.
11. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care 1998;36(1): 8-27.
12. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373-383.
13. Hilbe J. Negative Binomial Regression. 2nd ed. Cambridge: Cambridge University Press, 2011.
14. Brown AJ, Prescott C. Applied Mixed Models in Medicine. Chicester: Wiley, 2006.
15. Little R, Rubins D. Statistical Analysis with Missing Data. New York: Wiley, 1987.
16. Dudeck MA, Horan TC, Peterson KD, et al. National Healthcare Safety Network (NHSN) Report, data summary for 2010, deviceassociated module. Am J Infect Control 2011;39(10):798-816.
17. Cook DJ, Walter SD, Cook RJ, et al. Incidence of and risk factors for ventilator-associated pneumonia in critically ill patients. Ann Intern Med 1998;129(6):433-440.
18. Koulenti D, Lisboa T, Brun-Buisson C, et al. Spectrum of practice in the diagnosis of nosocomial pneumonia in patients requiring mechanical ventilation in European intensive care units. Crit Care Med 2009;37(8):2360-2368.
19. Sievert DM, Ricks P, Edwards JR, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2009-2010. Infect Control Hosp Epidemiol 2013;34(1):1-14.
20. Papazian L, Thomas P, Garbe L, et al. Bronchoscopic or blind sampling techniques for the diagnosis of ventilator-associated pneumonia. Am J Respir Crit Care Med 1995;152(6):1982-1991.
21. Torres A, El-Ebiary M, Padro L, et al. Validation of different techniques for the diagnosis of ventilator-associated pneumonia: comparison with immediate postmortem pulmonary biopsy. Am J Respir Crit Care Med 1994;149(2):324-331.
22. Marquette CH, Copin MC, Wallet F, et al. Diagnostic tests for pneumonia in ventilated patients: prospective evaluation of diagnostic accuracy using histology as a diagnostic gold standard. Am J Respir Crit Care Med 1995;151(6):1878-1888.
23. Kirtland SH, Corley DE, Winterbauer RH, et al. The diagnosis of ventilator-associated pneumonia: a comparison of histologic, microbiologic, and clinical criteria. Chest 1997;112(2):445-457.
24. Papazian L, Autillo-Touati A, Thomas P, et al. Diagnosis of ventilator-associated pneumonia: an evaluation of direct examination and presence of intracellular organisms. Anesthesiology 1997;87(2):268-276.
25. Fabregas N, Ewig S, Torres A, et al. Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 1999; 54(10):867-873.
26. Klompas M. Ventilator-associated events surveillance: a patient safety opportunity. Curr Opin Crit Care 2013;19(5):424-431.